Journal of Psychopharmacology
Journal of Psychopharmacology is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 143. It has an SJR impact factor of 1,708 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,708.
Journal of Psychopharmacology focuses its scope in these topics and keywords: administration, female, selective, healthy, depressive, controlled, fluoxetine, dysregulation, dopamine, dynamics, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,708
H-index
143
Docs (year)
130
Docs 3y
405
Total refs
8096
Cites 3y
2170
Citable 3y
369
Cites/Doc 2y
5.73
Ref/Doc
62.28
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Amphetamine decreases the expression and acquisition of appetitive conditioning but increases the acquisition of anticipatory responding over a trace interval
View moreWhat do brain imaging studies tell us about anxiety disorders?
View moreCan you enhance executive control without glucose? The effects of fructose on problem solving
View moreBehavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats
View moreAugmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study
View moreAugmentation and combination strategies for depression
View moreAntipsychotic prescribing quality and ethnicity - a study of hospitalized patients in south east London
View moreAntipsychotic prescribing in Black and White hospitalised patients
View moreAntipsychotic polypharmacy and augmentation strategies prior to clozapine initiation: a historical cohort study of 310 adults with treatment-resistant schizophrenic disorders
View moreAntipsychotic drug-induced acute laryngeal dystonia: two case reports and a mini review
View moreAntidepressant-like effect of creatine in mice involves dopaminergic activation
View moreAnti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1(s1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
View moreAnhedonia and depression severity dissociated by dmPFC resting-state functional connectivity in adolescents
View moreA case of pancytopenia
View moreAlcohol, wine and mental health: focus on dementia and stroke
View moreAlcohol selectively impairs negative self-relevant associations in young drinkers
View moreAdverse effects associated with the use of donepezil in general practice in England
View moreAdjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: Clinical and neuroimaging evidence
View moreADHD matures: time for practitioners to do the same?
View moreAcute mitragynine administration suppresses cortical oscillatory power and systems theta coherence in rats
View moreAcute ingestion of rosemary water: Evidence of cognitive and cerebrovascular effects in healthy adults
View moreA review of anti-inflammatory agents for symptoms of schizophrenia
View moreA proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia
View moreA naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia
View more